MedTrace Logo

Collaborative Urological Prosthetics Investigation Directive Research Group

NCT05100654 · Status: ACTIVE_NOT_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2026-02-02

No results posted yet for this study

Summary

The purpose of this study is to determine if an additional 6 days of oral antibiotics decreases the risk of penile prosthesis infection after implantation.

Conditions

Interventions

DRUG

Bactrim

Patients will be given 6 days of oral antibiotics based on local biograms, patient allergies and renal and liver function

DRUG

Doxycycline

Patients will be given 6 days of oral antibiotics based on local biograms, patient allergies and renal and liver function

DRUG

Ciprofloxacin

Patients will be given 6 days of oral antibiotics based on local biograms, patient allergies and renal and liver function

DRUG

Augmentin

Patients will be given 6 days of oral antibiotics based on local biograms, patient allergies and renal and liver function

Sponsors & Collaborators

  • Loyola University

    collaborator OTHER

  • University of Chicago

    lead OTHER

Principal Investigators

  • Sarah Faris, MD · University of Chicago Department of Surgery

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
90 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-22
Primary Completion
2027-12-31
Completion
2028-01-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05100654 on ClinicalTrials.gov